Learn More  
About BT

Who Is BT For?

The Alair™ Bronchial Thermoplasty System is indicated for the treatment of severe persistent asthma in patients 18 years and older whose asthma is not well controlled with inhaled corticosteroids and long-acting beta-agonists (ICS and LABA), such as Advair™, Symbicort™, Breo™, or Dulera™.

Your asthma may not be well controlled if you are:

  • Still having severe asthma attacks
  • Adjusting your lifestyle to avoid asthma triggers
  • Absent from work, school, or daily activities because of your severe asthma

BT Is Not Right For Patients Who:

  • Are under 18 years old
  • Have a pacemaker, internal defibrillator, or other implantable electronic device
  • Have known sensitivity to medications required to perform bronchoscopy, including lidocaine, atropine and benzodiazepines
  • Have previously been treated with BT

Have Questions About Bronchial Thermoplasty?

Call BT CareConnectTM to speak with a trained healthcare professional who can help you.
 
Monday-Friday 9:00 AM - 8:00 PM Eastern

Call (888) 272-8440 

What to Expect:

BT is not a cure for your severe asthma but may help to improve your asthma-related quality of life. It's different for each patient but clinical trials showed that many patients experienced reductions in severe asthma attacks, ER visits, and hospitalizations for respiratory symptoms, and fewer days lost from work, school, and other daily activities due to severe asthma. 

Brief Statement of Relevant Indications for Use, Contraindications, Warnings, and Adverse Events:The Alair™ Bronchial ThermoplastySystem is indicated for the treatment of severe persistent asthma in patients 18 years and older whose asthma is not well controlled with inhaled corticosteroids and long-acting beta-agonists. The Alair System is not for use in patients with an active implantable electronic device or known sensitivity to medications used in bronchoscopy. Previously treated airways of the lung should not be retreated with the Alair System. Patients should be stable and suitable to undergo bronchoscopy. The most common side effect of BT is an expected transient increase in the frequency and worsening of respiratory-related symptoms. ENDO-551804-AA May 2018

References

  1. Castro M, et al, for the AIR2 Trial Study Group. Am J Respir Crit Care Med. 2010;181:116-124.

Top